miRNA in Pediatric Gastritis
ConditionHELICOBACTER PYLORI INFECTIONS
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-18
SponsorBenha University
About this trial
The goal of this clinical trial is to assess the differential expression of miR-155 and miRNA-204 in relation to gastritis, and assess their relation with the presence of H. pylori in children.
Eligibility criteria
Qualifiers
peptic-like dyspepsia (identified by two or more symptoms such as periodic pain, pain relief with food or antacid, pre-meal or hunger-induced pain, nausea/vomiting, and nighttime pain),
dysmotility-like dyspepsia (characterized by abdominal distension, anorexia, weight loss, pain worsening with food/milk, and belching),
and reflux-like dyspepsia (manifesting as heartburn, chest pain
Disqualifiers
None
Trial design
Treatments tested in this trial
- miRNA gene expression
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov